Conformia sells intellectual property to Oracle, disbands

Conformia Software, maker of software used to manage software cycles end-to-end, has sold its intellectual property assets to Oracle for an undisclosed amount. The company, which specialized in drug development processes, appears to now be defunct. Redwood Shores, Calif.-based Oracle, on the other hand, plans to merge this technology with its existing Oracle Agile Product Lifecycle Management product, which also assists and monitors drug development from beginning to commercialization.

Conformia previously raised $34 million in capital from Foundation Capital, Mentor Capital Group, Jafco Ventures, NextLevel Venture Partners, SAP AG, Sequoia Capital, Stanford Univeristy, WS Investment and Capital Investors.

Next Story: Sega appoints new execs, aligns Western markets
Previous Story: Gydget buy pays off for Adgregate in new product rollout